These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6773784)
1. Modification of the proline residue of TRH enhances biological activity and inhibits degradation. Brewster D; Dettmar PW; Lynn AG; Metcalf G; Morgan BA; Rance MJ Eur J Pharmacol; 1980 Aug; 66(1):65-71. PubMed ID: 6773784 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration. Yamamura M; Kinoshita K; Nakagawa H; Tanaka T; Maeda K; Ishida R Jpn J Pharmacol; 1990 Aug; 53(4):451-61. PubMed ID: 2120494 [TBL] [Abstract][Full Text] [Related]
3. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats. Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433 [TBL] [Abstract][Full Text] [Related]
4. Thyrotropin-releasing hormone (TRH) analogues show enhanced CNS selectivity because of increased biological stability. Metcalf G; Dettmar PW; Lynn AG; Brewster D; Havler ME Regul Pept; 1981 Sep; 2(5):277-84. PubMed ID: 6795691 [TBL] [Abstract][Full Text] [Related]
5. A radioimmunoassay for the measurement of pyroglutamyl-histidyl-proline, a proposed thyrotropin releasing hormone metabolite. Visser TJ; Klootwijk W; Docter R; Hennemann G J Clin Endocrinol Metab; 1975 Apr; 40(4):742-5. PubMed ID: 805158 [TBL] [Abstract][Full Text] [Related]
6. Regulatory peptides as a source of new drugs--the clinical prospects for analogues of TRH which are resistant to metabolic degradation. Metcalf G Brain Res; 1982 Nov; 257(3):389-408. PubMed ID: 6816389 [TBL] [Abstract][Full Text] [Related]
7. TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects. Angyal R; Strbák V; Alexandrová M; Kruszyński M Endocrinol Exp; 1985 Dec; 19(4):213-9. PubMed ID: 3002750 [TBL] [Abstract][Full Text] [Related]
8. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions. Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogs containing a 1-substituted 2-oxoimidazolidine moiety. Maeda H; Suzuki M; Sugano H; Yamamura M; Ishida R Int J Pept Protein Res; 1989 Jun; 33(6):403-11. PubMed ID: 2506142 [TBL] [Abstract][Full Text] [Related]
11. A new biological contribution of cyclo(His-Pro) to the peripheral inhibition of pancreatic secretion. Fragner P; Presset O; Bernad N; Martinez J; Roze C; Aratan-Spire S Am J Physiol; 1997 Dec; 273(6):E1127-32. PubMed ID: 9435528 [TBL] [Abstract][Full Text] [Related]
12. Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio. Kagabu Y; Mishiba T; Okino T; Yanagisawa T Gen Comp Endocrinol; 1998 Sep; 111(3):395-403. PubMed ID: 9707485 [TBL] [Abstract][Full Text] [Related]
13. Biological activity of TRH thionalogue and its diastereoisomers. Alexandrová M; Strbák V; Herman ZS; Stachura Z; Kruszyński M Endocrinol Exp; 1987 Mar; 21(1):43-9. PubMed ID: 3106009 [TBL] [Abstract][Full Text] [Related]
14. Effects of thyrotropin-releasing hormone and a thyrotropin releasing hormone analog on growth and selected plasma hormones in lambs. Muir LA; Wien S J Anim Sci; 1983 Jul; 57(1):139-45. PubMed ID: 6411671 [TBL] [Abstract][Full Text] [Related]
15. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH). Webster VA; Griffiths EC; Slater P Regul Pept; 1982 Dec; 5(1):43-51. PubMed ID: 6820171 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of brain inactivation of centrally-acting thyrotrophin-releasing hormone (TRH) analogues: a high-performance liquid chromatography study. Griffiths EC; McDermott JR; Smith AI Regul Pept; 1982 Dec; 5(1):1-11. PubMed ID: 6820170 [TBL] [Abstract][Full Text] [Related]
17. Biologically stable analogues of TRH with increased neuropharmacological potency. Brewster D; Dettmar PW; Metcalf G Neuropharmacology; 1981 May; 20(5):497-503. PubMed ID: 6787451 [No Abstract] [Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel, centrally-acting thyrotropin-releasing hormone analogues. Prokai-Tatrai K; Perjési P; Zharikova AD; Li X; Prokai L Bioorg Med Chem Lett; 2002 Aug; 12(16):2171-4. PubMed ID: 12127530 [TBL] [Abstract][Full Text] [Related]
19. Attempts toward biosynthesis of the thyrotropin-releasing hormone and studies on its breakdown in hypothalamic tissue preparations. Bauer K; Lipmann F Endocrinology; 1976 Jul; 99(1):230-42. PubMed ID: 820546 [TBL] [Abstract][Full Text] [Related]
20. Antinociceptive activity of TRH metabolites in the mouse. Reny-Palasse V; Rips R Pain; 1987 Aug; 30(2):259-269. PubMed ID: 3118323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]